Soluble TLR2 is present in human amniotic fluid and modulates the intraamniotic inflammatory response to infection

Journal of Immunology

Volumn 182, Issue 11, 2009, Pages 7244-7253

  Dulay, Antonette T ^a   Buhimschi, Catalin S ^a   Zhao, Guomao ^a   Oliver, Emily A ^b   Mbele, Ayanda ^c   Jing, Shichu ^a   Buhimschi, Irina A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

MONENSIN; PEPTIDE; SOLUBLE TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; CYTOKINE;

AMNION FLUID; AMNIONITIS; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPLANT; FEMALE; GESTATIONAL AGE; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOREGULATION; IN VITRO STUDY; INNATE IMMUNITY; PLACENTA VILLUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROCESSING; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; CASE CONTROL STUDY; CHEMISTRY; DOWN REGULATION; IMMUNOLOGY; INFECTION; INFLAMMATION; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION; SOLUBILITY;

AMNIOTIC FLUID; CASE-CONTROL STUDIES; CYTOKINES; DOWN-REGULATION; FEMALE; HUMANS; IMMUNITY, INNATE; INFECTION; INFLAMMATION; PREGNANCY; PREGNANCY COMPLICATIONS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SOLUBILITY; TOLL-LIKE RECEPTOR 2;

EID: 67449152216     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803517     Document Type: Article

References (60)

1. Kimbrell, D. A., and B. Beutler. 2001. The evolution and genetics of innate immunity. Nat. Rev. Genet. 2: 256-267.
2. Vasselon, T., and P. A. Detmers. 2002. Toll receptors: a central element in innate immune responses. Infect. Immun. 70: 1033-1041.
3. Rindsjo, E., U. Holmilliliterund, E. Sverremark-Ekstrom, N. Papadogiannakis, and A. Scheynius. 2007. Toll-like receptor-2 expression in normal and pathologic human placenta. Hum. Pathol. 38: 468-473.
4. Ma, Y., G. Krikun, V. M. Abrahams, G. Mor, and S. Guller. 2007. Cell type-specific expression and function of Toll-like receptors 2 and 4 in human placenta: implications in fetal infection. Placenta 28: 1024-1031.
5. Krikun, G., C. J. Lockwood, V. M. Abrahams, G. Mor, M. Paidas, and S. Guller. 2007. Expression of Toll-like receptors in the human decidua. Histol. Histopathol. 22: 847-854.
6. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376.
7. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274: 17406-17419.
8. Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, and D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274: 33419-33425.
9. Jones, B. W., K. A. Heldwein, T. K. Means, J. J. Saukkonen, and M. J. Fenton. 2001. Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann. Rheum. Dis. 60(Suppl. 3): iii6-12.
10. Takeda, K., and S. Akira. 2004. TLR signalling pathways. Semin. Immunol. 16: 3-9.
11. Watters, T. M., E. F. Kenny, and L. A. O'Neill. 2007. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Immunol. Cell Biol. 85: 411-419.
12. Klaffenbach, D., W. Rascher, M. Röllinghoff, J. Dötsch, U. Meissner, and M. Schnare. 2005. Regulation and signal transduction of Toll-like receptors in human chorioncarcinoma cell lines. Am. J. Reprod. Immunol. 53: 77-84.
13. Mantovani, A., C. Garlanda, M. Locati, T. V. Rodriguez, S. G. Feo, B. Savino, and A. Vecchi. 2007. Regulatory pathways in inflammation. Autoimmun. Rev. 7: 8-11.
14. Kuroishi, T., Y. Tanaka, A. Sakai, Y. Sugawara, K. Komine, and S. Sugawara. 2007. Human parotid saliva contains soluble Toll-like receptor (TLR) 2 and modulates TLR2-mediated interleukin-8 production by monocytic cells. Mol. Immunol. 44: 1969-1976.
15. LeBouder, E., J. E. Rey-Nores, N. K. Rushmere, M. Grigorov, S. D. Lawn, M. Affolter, G. E. Griffin, P. Ferrara, E. J. Schiffrin, B. P. Morgan, and M. O. Labéta. 2003. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J. Immunol. 171: 6680-6689. (Pubitemid 37532100)
16. Buhimschi, I. A., and C. S. Buhimschi. 2008. Proteomics of the amniotic fluid in assessment of the placenta: relevance for preterm birth. Placenta 29(Suppl. A): S95-101.
17. Gelber, S. E., A. M. Bongiovanni, C. Jean-Pierre, I. M. Linhares, D. W. Skupski, and S. S. Witkin. 2007. Antibodies to the 70 kDa heat shock protein in midtrimester amniotic fluid and intraamniotic immunity. Am. J. Obstet. Gynecol. 197: 278.e1-4
18. Menon, R., P. Thorsen, I. Vogel, B. Jacobsson, N. Morgan, L. Jiang, C. Li, S. M. Williams, and S. J. Fortunato. 2008. Racial disparity in amniotic fluid concentrations of tumor necrosis factor (TNF)-alpha and soluble TNF receptors in spontaneous preterm birth. Am. J. Obstet. Gynecol. 198: 533.e1-10
19. Jacobsson, B., I. Mattsby-Baltzer, and H. Hagberg. 2005. Interleukin-6 and interleukin-8 in cervical and amniotic fluid: relationship to microbial invasion of the chorioamniotic membranes. BJOG 112: 719-724.
20. Buhimschi, I. A., R. Christner, and C. S. Buhimschi. 2005. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG 112: 173-181.
21. Yoshio, H., M. Tollin, G. H. Gudmundsson, H. Lagercrantz, H. Jornvall, G. Marchini, and B. Agerberth. 2003. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr. Res. 53: 211-216.
22. Niemelä, A., M. Kulomaa, P. Vija, P. Tuohimaa, and S. Saarikoski. 1989. Lactoferrin in human amniotic fluid. Hum. Reprod. 4: 99-101.
23. Roos, T., T. R. Martin, J. T. Ruzinski, D. J. Leturcq, S. L. Hillier, D. L. Patton, and D. A. Eschenbach. 1997. Lipopolysaccharide binding protein and soluble CD14 receptor protein in amniotic fluid and cord blood in patients at term. Am. J. Obstet. Gynecol. 177: 1230-1237.
24. Edwards, R. K., P. Clark, G. J. Locksmith, and P. Duff. 2001. Performance characteristics of putative tests for subclinical chorioamnionitis. Infect. Dis. Obstet. Gynecol. 9: 209-214.
25. Garry, D., R. Figueroa, M. Aguero-Rosenfeld, E. Martinez, P. Visintainer, and N. Tejani. 1996. A comparison of rapid amniotic fluid markers in the prediction of microbial invasion of the uterine cavity and preterm delivery. Am. J. Obstet. Gynecol. 175: 1336-1341.
26. Schwartz, A. L., C. S. Forster, P. A. Smith, and G. C. Liggins. 1977. Human amnion metabolism: in vitro maintenance. Am. J. Obstet. Gynecol. 127: 470-474.
27. Magloire, L. K., C. S. Buhimschi, C. M. Pettker, A. K. Sfakianaki, B. D. Hamar, V. Bhandari, and I. A. Buhimschi. 2006. Lactate dehydrogenase isoform activity mapping in patients with intra-amniotic infection. Am. J. Obstet. Gynecol. 195: 1045-1052.
28. Rasband, W. S. 1997-2007. ImageJ. U.S. National Institutes of Health, Bethesda, MD (http://rsb.info.nih.gov/ij/).
29. McCarthy, K. S., L. S. Miller, C. B. Cox, J. Konrath, and K. S. McCarthy, Sr. 1985. Estrogen receptor analysis: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch. Pathol. Lab. Med. 109: 716-721.
30. Zammit, C., R. Barnard, J. Gomm, R. Coope, S. Shousha, C. Coombes, and C. Johnston. 2001. Altered intracellular localization of fibroblast growth factor receptor 3 in human breast cancer. J. Pathol. 194: 27-34.
31. Hinkle, D. E., W. Wiersma, and S. G. Jurs. 1988. Applied Statistics for the Behavioral Sciences, 2nd Ed. Houghton Mifflin, Boston.
32. Mollenhauer, H. H., D. J. Morré, and L. D. Rowe. 1990. Alteration of intracellular traffic by monensin; mechanism, specificity and relationship to toxicity. Biochim. Biophys. Acta 1031: 225-246.
33. Schuster-Woldan, N., M. Hilton, and T. Wilson. 1997. RU486 inhibits synthesis of an endogenous inhibitor of cell arachidonate release from choriodecidua tissue. Mol. Hum. Reprod. 3: 743-747.
34. Meeusen, E. N., R. J. Bischof, and C. S. Lee. 2001. Comparative T-cell responses during pregnancy in large animals and humans. Am. J. Reprod. Immunol. 46: 169-179.
35. Zähringer, U., B. Lindner, S. Inamura, H. Heine, and C. Alexander. 2008. TLR2: promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213: 205-224.
36. Buhimschi, C. S., A. T. Dulay, S. Abdel-Razeq, G. Zhao, S. Lee, E. J. Hodgson, V. Bhandari, and I. A. Buhimschi. 2009. Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and pre-term birth. BJOG 116: 257-267.
37. Brun-Buisson, C., F. Doyon, J. Carlet, P. Dellamonica, F. Gouin, A. Lepoutre, J. C. Mercier, G. Offenstadt, and B. Régnier. 1995. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units: French ICU Group for Severe Sepsis. J. Am. Med. Assoc. 274: 968-974.
38. Benirschke, K., and J. A. Robb. 1987. Infectious causes of fetal death. Clin. Obstet. Gynecol. 30: 284-294.
39. Lockwood, C. J., F. Arcuri, P. Toti, C. D. Felice, G. Krikun, S. Guller, L. F. Buchwalder, and F. Schatz. 2006. Tumor necrosis factor-α and interleukin-1β regulate interleukin-8 expression in third trimester decidual cells: implications for the genesis of chorioamnionitis. Am. J. Pathol. 169: 1294-1302.
40. Buhimschi, C. S., V. Bhandari, B. D. Hamar, M. O. Bahtiyar, G. Zhao, A. K. Sfakianaki, C. M. Pettker, L. Magloire, E. Funai, E. R. Norwitz, et al. 2007. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med. 4: e18.
41. Buhimschi, I. A., E. Zambrano, C. M. Pettker, M. O. Bahtiyar, M. Paidas, V. A. Rosenberg, S. Thung, C. M. Salafia, and C. S. Buhimschi. 2008. Using proteomic analysis of the human amniotic fluid to identify histologic chorioamnionitis. Obstet. Gynecol. 111: 403-412.
42. Hauguel-de Mouzon, S., and M. Guerre-Millo. 2006. The placenta cytokine network and inflammatory signals. Placenta 27: 794-798.
43. Otsuki, K., A. Yoda, H. Saito, Y. Mitsuhashi, Y. Toma, Y. Shimizu, and T. Yanaihara. 1999. Amniotic fluid lactoferrin in intrauterine infection. Placenta 20: 175-179.
44. Kim, J. Y., S. Y. Lee, S. C. Park, S. Y. Shin, S. J. Choi, Y. Park, and K. S. Hahm. 2007. Purification and antimicrobial activity studies of the N-terminal fragment of ubiquitin from human amniotic fluid. Biochim. Biophys. Acta 1774: 1221-1226.
45. Rose-John, S., J. Scheller, G. Elson, and S. A. Jones. 2006. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J. Leukocyte Biol. 80: 227-236.
46. Buhimschi, I. A., G. Zhao, C. M. Pettker, M. O. Bahtiyar, L. K. Magloire, S. Thung, T. Fairchild, and C. S. Buhimschi. 2007. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am. J. Obstet. Gynecol. 196: 181.e1-13
47. Kim, J. Y., S. Y. Lee, S. C. Park, S. Y. Shin, S. J. Choi, Y. Park, and K. S. Hahm. 2007. Purification and antimicrobial activity studies of the N-terminal fragment of ubiquitin from human amniotic fluid. Biochim. Biophys. Acta 1774: 1221-1226.
48. Hyakushima, N., H. Mitsuzawa, C. Nishitani, H. Sano, K. Kuronuma, M. Konishi, T. Himi, K. Miyake, and Y. Kuroki. 2004. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling. J. Immunol. 173: 6949-6954. (Pubitemid 39541083)
49. Reddy, P., J. L. Slack, R. Davis, D. P. Cerretti, C. J. Kozlosky, R. A. Blanton, D. Shows, J. J. Peschon, and R. A. Black. 2000. Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme. J. Biol. Chem. 275: 14608-14614.
50. Rindsjö, E., U. Holmlund, E. Sverremark-Ekström, N. Papadogiannakis, and A. Scheynius. 2007. Toll-like receptor-2 expression in normal and pathologic human placenta. Hum. Pathol. 38: 468-473.
51. Hayashi, F., T. K. Means, and A. D. Luster. 2003. Toll-like receptors stimulate human neutrophil function. Blood 102: 2660-2669.
52. Watts, D., M. Krohn, S. Hillier, and D. Eschenbach. 1992. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet. Gynecol. 79: 351-357.
53. Benjamin, D. K., E. DeLong, C. M. Cotten, H. P. Garges, W. J. Steinbach, and R. H. Clark. 2004. Mortality following blood culture in premature infants: increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia. J. Perinatol. 24: 175-180.
54. Stoll, B. J., N. Hansen, A. A. Fanaroff, L. L. Wright, W. A. Carlo, R. A. Ehrenkranz, J. A. Lemons, E. F. Donovan, A. R. Stark, J. E. Tyson, et al. 2002. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N. Engl. J. Med. 347: 240-247.
55. Ghosh, T. K., D. J. Mickelson, J. C. Solberg, K. E. Lipson, J. R. Inglefield, and S. S. Alkan. 2007. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-α. Int. Immunopharmacol. 7: 1111-1121.
56. Lee, M. S., and Y. Y. Kim. 2007. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem. 76: 447-480.
57. Levy, O., R. B. Sisson, J. Kenyon, E. Eichenwald, A. B. Macone, and D. Goldmann. 2000. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of Gram-negative bacteria tested in neonatal cord blood ex vivo. Infect. Immun. 68: 5120-5125.
58. Levy, O. 2007. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7: 379-390.
59. Witkin, S. S., I. M. Linhares, and P. Giraldo. 2007. Bacterial flora of the female genital tract: function and immune regulation. Best. Pract. Res. Clin. Obstet. Gynaecol. 21: 347-354.
60. Han, Y. W., T. Shen, P. Chung, I. A. Buhimschi, and C. S. Buhimschi. 2009. Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. J. Clin. Microbiol. 47: 38-47.